Free Trial

Hyperfine (NASDAQ:HYPR) Shares Down 2.8% - Time to Sell?

Hyperfine logo with Medical background

Shares of Hyperfine, Inc. (NASDAQ:HYPR - Get Free Report) dropped 2.8% during mid-day trading on Monday . The stock traded as low as $0.75 and last traded at $0.77. Approximately 630,203 shares were traded during trading, a decline of 29% from the average daily volume of 883,067 shares. The stock had previously closed at $0.80.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. B. Riley restated a "buy" rating on shares of Hyperfine in a research report on Tuesday, June 3rd. Lake Street Capital started coverage on shares of Hyperfine in a research note on Monday, March 24th. They issued a "buy" rating and a $1.50 target price for the company. Finally, Wells Fargo & Company reduced their target price on Hyperfine from $1.29 to $0.68 and set an "equal weight" rating on the stock in a report on Wednesday, May 14th.

Read Our Latest Research Report on HYPR

Hyperfine Price Performance

The stock has a 50 day moving average price of $0.69 and a two-hundred day moving average price of $0.89. The company has a market capitalization of $62.21 million, a price-to-earnings ratio of -1.40 and a beta of 0.95.

Hyperfine (NASDAQ:HYPR - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported ($0.12) earnings per share for the quarter, meeting the consensus estimate of ($0.12). Hyperfine had a negative net margin of 309.42% and a negative return on equity of 57.54%. The firm had revenue of $2.14 million during the quarter, compared to analysts' expectations of $2.82 million. Sell-side analysts forecast that Hyperfine, Inc. will post -0.57 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of HYPR. Virtu Financial LLC bought a new position in Hyperfine in the 4th quarter valued at $25,000. Renaissance Technologies LLC lifted its stake in shares of Hyperfine by 32.9% during the fourth quarter. Renaissance Technologies LLC now owns 212,300 shares of the company's stock valued at $187,000 after acquiring an additional 52,500 shares during the period. Wealth Enhancement Advisory Services LLC boosted its holdings in Hyperfine by 64.3% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company's stock valued at $72,000 after acquiring an additional 32,093 shares during the last quarter. AMH Equity Ltd bought a new position in Hyperfine in the first quarter valued at about $90,000. Finally, EP Wealth Advisors LLC acquired a new stake in Hyperfine in the first quarter worth about $25,000. Institutional investors own 15.03% of the company's stock.

Hyperfine Company Profile

(Get Free Report)

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.

Featured Stories

Should You Invest $1,000 in Hyperfine Right Now?

Before you consider Hyperfine, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyperfine wasn't on the list.

While Hyperfine currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines